Improved vaccination strategies
for older adults

A collaborative effort by the ISOLDA consortium to lower morbidity and mortality due to viral diseases in adults aged 65 years or over.

Who are we?

Find out more about the ISOLDA consortium.

Our activities

Learn how ISOLDA aims at developing vaccines against viral diseases that are better tailored to older adults.

News and updates

Stay informed about the developments in the ISOLDA consortium.

Contact us

Reach out to us for more information.

September 27, 2024
Publications related to project ISOLDA – part 5
Today, the ISOLDA consortium is proud to present seven additional publications resulting from our research collaboration.
Read More
April 10, 2023
Publications related to project ISOLDA – part 4
Today, the ISOLDA consortium is proud to present seven additional publications resulting from our research collaboration.
Read More
March 31, 2023
Publications related to project ISOLDA – part 3
Part 3 of this blog series presents the next five peer-reviewed papers resulting from the ISOLDA consortium.
Read More
March 21, 2023
Publications related to project ISOLDA – part 2
Following part 1 of this blog series, the consortium is proud to present the next five academic publications related to project ISOLDA...
Read More
March 6, 2023
Publications related to project ISOLDA – part 1
Since 2020, the ISOLDA consortium has been collaborating to develop improved vaccines against viral infections for older adults. The collaboration has resulted in a number of peer-reviewed articles in academic...
Read More
January 28, 2020
ISOLDA consortium kicks off in Amsterdam
On January 28th 2020, the ISOLDA consortium officially started its activities by means of a kick-off meeting in Amsterdam, at the Sheraton Amsterdam Airport Conference Center of Schiphol.
Read More
January 1, 2020
EU awards contract to ISOLDA consortium
The EU Research and Innovation programme HORIZON 2020 has awarded a contract to the ISOLDA consortium, led by Stiftung Tieraerztliche Hochschule Hannover (TiHo), to develop improved vaccines against viral infections...
Read More